Overview
The State Budgetary Institution of the Rostov Region's "Regional Clinical Centre of Phthisiopulmonology" has given LLC "Advance Trading" a contract worth ₽280,437,997.30 to supply the antibiotic linezolid. The agreement, which was finalised on December 8, 2025, will strengthen the region's ability to treat tuberculosis and bacterial infections until December 31, 2026.
Details of the Contract
Linezolid will be supplied to several locations in the Rostov region under the terms of the contract, including Taganrog, Novocherkassk, Bataysk, Rostov-on-Don, Kamensk-Shakhtinsky, Shakhty, and nearby rural settlements. With a performance security of ₽28,043,799.73, the contract execution starts on January 1, 2026, guaranteeing on-time delivery and adherence to quality standards.
Under Federal Law No. 44-FZ, an electronic auction was used for the procurement, offering a clear selection procedure. The contract did not require banking or treasury support.
Organisations Involved
The Regional Clinical Centre of Phthisiopulmonology, a significant medical facility in Rostov that treats respiratory conditions like tuberculosis, is the buyer. The supplier, LLC "Advance Trading," is a pharmaceutical distributor with headquarters in Moscow that specialises in hospital drugs and medical supplies.
Importance of the Agreement
The continuous supply of Linezolid, an essential antibiotic for treating infections resistant to multiple drugs, is guaranteed by this contract. The Rostov Regional Clinical Centre strengthens its preparedness for public health and the standard of patient care across several municipalities by obtaining this agreement. The purchase also demonstrates the area's dedication to timely delivery of necessary medications and strategic management of the healthcare supply.
Concerning LLC "Advance Trading"
LLC "Advance Trading", which was founded in Moscow, has made a name for itself as a reliable provider of pharmaceutical and medical goods. The business offers dependable distribution networks, guaranteeing that hospitals and other healthcare facilities receive essential medications on schedule.
In conclusion
The Rostov Region's proactive approach to healthcare is demonstrated by the awarding of this ₽280 million contract for Linezolid supply, which guarantees that hospitals continue to be prepared to manage complex bacterial infections and uphold high treatment standards.
#RussiaContractAward #ProcurementNews #GovernmentContractsRussia #HealthcareContractsRussia #AwardedTendersRussia #PharmaceuticalSupplyRussia #LinezolidSupply #RegionalClinicalCenterRostov #MedicalProcurementRussia #LLCAdvanceTrading
